Depression, stress and immunological activation: the role of cytokines in depressive disorders (Q41705538)

7 October 2017

1 reference

title

Depression, stress and immunological activation: the role of cytokines in depressive disorders (English)

1 reference

7 October 2017

1 reference

Connor TJ

1

1 reference

PubMed ID

9472719

7 October 2017

Leonard BE

series ordinal

2

1 reference

PubMed ID

9472719

7 October 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

7 October 2017

1 reference

7 October 2017

62

1 reference

7 October 2017

583-606

1 reference

7 October 2017

7

1 reference

Psychoneuroendocrinological Effects on the Immune Response

7 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Cytokines and food intake: the relevance of the immune system to the student of ingestive behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Abnormal zymosan-induced neutrophil chemiluminescence as a marker of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Lymphocyte mitogenesis, immunoglobulin and complement levels in depressed patients and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Impaired lymphocyte stimulation by mitogens in severely depressed patients. A complex interface with HPA-axis hyperfunction, noradrenergic activity and the ageing process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Reduction of immune function in life stress and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Depression and reduced natural killer cytotoxicity: a longitudinal study of depressed patients and control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Major depressive disorder and immunity. Role of age, sex, severity, and hospitalization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

A controlled study of cellular immune function in affective disorders before and during somatic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Mitogen-stimulated lymphocyte proliferation and pituitary hormones in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Depression and immunocompetence: a review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Depressed lymphocyte function after bereavement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Plasma cortisol and natural killer cell activity during bereavement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Marital quality, marital disruption, and immune function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Spousal caregivers of dementia victims: longitudinal changes in immunity and health.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Impaired natural killer cell activity during bereavement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Stressful events, dysphoric mood, and immune responsiveness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

The monocyte-T-lymphocyte hypothesis of major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

The macrophage theory of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Cytokines and the nervous system. I: Expression and recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Cellular localization of interleukin 6 mRNA and interleukin 6 receptor mRNA in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Endotoxin administration stimulates cerebral catecholamine release in freely moving rats as assessed by microdialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Increased biogenic amine release in mouse hypothalamus following immunological challenge: antagonism by indomethacin.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Behavioural effects of peripherally injected interleukin-1: role of prostaglandins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-1-induced anorexia in the rat. Influence of prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Intraperitoneal administration of recombinant human interleukin-1β inhibits osmotic thirst in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Bidirectional transport of interleukin-1 alpha across the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-1 beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Changes in immunoglobulin, complement and acute phase protein levels in the depressed patients and normal controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Higher alpha 1-antitrypsin, haptoglobin, ceruloplasmin and lower retinol binding protein plasma levels during depression: further evidence for the existence of an inflammatory response during that illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Increased serum interleukin-1-receptor-antagonist concentrations in major depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Increased neopterin and interferon-gamma secretion and lower availability of L-tryptophan in major depression: further evidence for an immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Indicators of immune activation in major depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Neutrophil and monocyte phagocytosis in depressed patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Cytokine production and serum proteins in depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Cytokine production in major depressed patients before and after clomipramine treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Glucocorticoids and the genesis of depressive illness. A psychobiological model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Neuroendocrine regulation of in vivo cytokine production and effects: I. In vivo regulatory networks involving the neuroendocrine system, interleukin-1 and tumor necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

The role of interleukin-1 and tumor necrosis factor alpha in the neurochemical and neuroendocrine responses to endotoxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Acute heat stress protects rats against endotoxin shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

11beta-Hydroxysteroid dehydrogenase in the brain: a novel regulator of glucocorticoid action?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Behavioral assessment of patients treated with alpha-interferon.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interferons as mediators of psychiatric morbidity. An investigation in a trial of recombinant alpha-interferon in hepatitis-B carriers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Endotoxin produces a depressive-like episode in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Affective disorders in multiple sclerosis. Review and recommendations for clinical research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Allergy and depression: a neurochemical threshold model of the relation between the illnesses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Disturbed emotionality in autoimmune MRL-lpr mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interactions between the gonadal steroids and the immune system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

The impact of stressors on immune and central neurotransmitter activity: bidirectional communication.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Time-dependent in vivo mesolimbic dopamine variations following antigenic challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-1 beta augments release of norepinephrine, dopamine, and serotonin in the rat anterior hypothalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Multiunit electrical activity in conscious rats during an immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Effects of interleukin-1beta and mild stress on alterations of norepinephrine, dopamine and serotonin neurotransmission: a regional microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

The immune response evokes changes in brain noradrenergic neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Alterations of monoamines in specific central autonomic nuclei following immunization in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Time-dependent variations of central norepinephrine and dopamine following antigen administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Effects of a primary immune response to T-cell dependent antigen on serotonin metabolism in frontal cortex: in vivo microdialysis study in freely moving Fischer 344 rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Activation of the hypothalamus-pituitary-adrenal axis by bacterial endotoxins: routes and intermediate signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Effect of bacterial endotoxin and interleukin-1 beta on hippocampal serotonergic neurotransmission, behavioral activity, and free corticosterone levels: an in vivo microdialysis study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Indomethacin prevents increased catecholamine turnover in rat brain following systemic endotoxin challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Activation of serotonergic and noradrenergic neurotransmission in the rat hippocampus after peripheral administration of bacterial endotoxin: involvement of the cyclo-oxygenase pathway.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-1 induces changes in norepinephrine metabolism in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Cytokine-specific central monoamine alterations induced by interleukin-1, -2 and -6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-1 stimulates the release of dopamine and dihydroxyphenylacetic acid from the hypothalamus in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-2 decreases accumbal dopamine efflux and responding for rewarding lateral hypothalamic stimulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Stress factors in affective diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Stress and the immune system in the etiology of anxiety and depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Immunomodulators and feeding regulation: a humoral link between the immune and nervous systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Sickness behavior as a new target for drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Intracerebroventricular administration of interleukin-1 to mice alters investigation of stimuli in a novel environment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Pyrogens specifically disrupt the acquisition of a task involving cognitive processing in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Spatial learning impairment in mice infected with Legionella pneumophila or administered exogenous interleukin-1-beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Antagonism of footshock stress-induced inhibition of intracranial self-stimulation by naloxone or methamphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Multiple neurochemical and behavioral consequences of stressors: implications for depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Desmethylimipramine promotes recovery of self-stimulation from the prefrontal cortex following footshock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Prevention of stressor-induced disturbances of self-stimulation by desmethylimipramine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Chronic mild stress-induced anhedonia: a realistic animal model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Animal model of depression: effects of electroconvulsive shock therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

The effect of chronic treatment with imipramine on the immunoreactivity of animals subjected to a chronic mild stress model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Antidepressant-like effects of dopamine agonists in an animal model of depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Reversal of stress-induced anhedonia by the dopamine receptor agonist, pramipexole.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Prearcuate cortex in the Cebus monkey has cortical and subcortical connections like the macaque frontal eye field and projects to fastigial-recipient oculomotor-related brainstem nuclei

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Effects of chronic stress on food intake in rats: influence of stressor intensity and duration of daily exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Centrally administered bacterial lipopolysaccharide depresses feeding in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Meal patterns in response to the intracerebroventricular administration of interleukin-1 beta in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Reduction in food and water intake induced by microinjection of interleukin-1 beta in the ventromedial hypothalamus of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Tumor necrosis factor and interleukin-1 beta: suppression of food intake by direct action in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Emptying and refilling of Ca2+ store in tracheal myocytes as indicated by ACh-evoked currents and contraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Repeated stress causes reversible impairments of spatial memory performance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Scopolamine blocks the effects of swim stress on memory retrieval in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Reduced long-term potentiation in the dentate gyrus of transgenic mice with cerebral overexpression of interleukin-6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interferon inhibits synaptic potentiation in rat hippocampus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-2 suppresses established long-term potentiation and inhibits its induction in the rat hippocampus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Effect of chronic treatment with the antidepressant tianeptine on the hypothalamo-pituitary-adrenal axis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

The interaction between interleukin-1 and glucocorticoids in the in vivo antibody response of mice to three concentrations of antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Tumor necrosis factor-alpha is a potent ACTH secretagogue: comparison to interleukin-1 beta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Cyclosporin A inhibits interleukin-2-induced release of corticotropin-releasing hormone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin-6 stimulates the secretion of adrenocorticotropic hormone in conscious, freely-moving rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Interleukin 6 modulates interleukin-1-and stress-induced activation of the hypothalamic-pituitary-adrenal axis in male rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Corticotropin-releasing factor administration elicits a stress-like activation of cerebral catecholaminergic systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Is corticotropin-releasing factor a mediator of stress responses?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

The effects of corticotrophin releasing factor (CRF) and handling stress on behavior in the elevated plus-maze test of anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

CRF antagonist partially reverses CRF- and stress-induced effects on feeding.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Inhibitory influence of corticotropin releasing factor on components of sexual behaviour in the male rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

A corticotropin-releasing factor antagonist reverses the stress-induced changes of exploratory behavior in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Corticotropin releasing factor (CRF) receptor antagonist blocks activating and 'anxiogenic' actions of CRF in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Antagonism of endogenous CRH systems attenuates stress-induced freezing behavior in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Corticotropin-releasing factor antagonist blocks stress-induced fighting in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Corticotropin-releasing factor: effects on the sympathetic nervous system and oxygen consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Corticotropin-releasing factor: actions on the sympathetic nervous system and metabolism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Corticotropin-releasing factor: a physiologic regulator of adrenal epinephrine secretion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Synthetic Competitive Antagonists of Corticotropin-Releasing Factor: Effect on ACTH Secretion in the Rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Corticotropin-releasing factor stimulates catecholamine release in hypothalamus and prefrontal cortex in freely moving rats as assessed by microdialysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Reduction of exploratory behavior by intraperitoneal injection of interleukin-1 involves brain corticotropin-releasing factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Opioid peptides mediate the suppressive effect of stress on natural killer cell cytotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Modulation of cellular immune responses by cold water swim stress in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Brain IL-1-induced immunosuppression occurs through activation of both pituitary-adrenal axis and sympathetic nervous system by corticotropin-releasing factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Suppression of splenic macrophage interleukin-1 secretion following intracerebroventricular injection of interleukin-1 beta: evidence for pituitary-adrenal and sympathetic control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Brain corticotropin-releasing hormone- and interleukin-1 beta-induced suppression of specific antibody production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Central corticotropin-releasing factor mediates the suppressive effect of stress on natural killer cytotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Stress-induced immune suppression: role of brain corticotropin releasing hormone and autonomic nervous system mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Animal models of depression: an overview

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

The effects of psychological stress on plasma interleukin-6 activity in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Immobilization stress may increase plasma interleukin-6 via central and peripheral catecholamines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Involvement of interleukin-1 in immobilization stress-induced increase in plasma adrenocorticotropic hormone and in release of hypothalamic monoamines in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Induction of plasma interleukin-6 by circulating adrenaline in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Stress Downregulates Lipopolysaccharide-Induced Expression of Proinflammatory Cytokines in the Spleen, Pituitary, and Brain of Mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Immobilization stress induces interleukin-1 beta mRNA in the rat hypothalamus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Amitriptyline attenuates the febrile response to a pyrogen in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Induction of interleukin-1 beta and interleukin-1 receptor antagonist mRNA by chronic treatment with various psychotropics in widespread area of rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Intracerebroventricular interleukin-1 receptor antagonist blocks the enhancement of fear conditioning and interference with escape produced by inescapable shock

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Antidepressant-like effects of CP-154,526, a selective CRF1 receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Olfactory bulbectomy alters alpha-1 acid glycoprotein levels in rat plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

Psychoneuroimmunology. The interface between behavior, brain, and immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Increased anxiety behaviors in autoimmune mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Psychological stress impairs spatial working memory: relevance to electrophysiological studies of hippocampal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2897%2900990-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0024-3205(97)00990-9

1 reference

7 October 2017

1 reference

PubMed ID

9472719